# Liothyronine sodium

NDC: 68382-583
Generic name: Liothyronine sodium
Labeler / Manufacturer: Zydus Pharmaceuticals (USA) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210201

FDA application: ANDA214803

## Active ingredients

- LIOTHYRONINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68382-583"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68382-583
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c54cf95f-6465-4203-b98b-a54ba5a26843